DiaMedica Therapeutics Inc. (DMAC) stock
DMACNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.79−0.54 (-5.79%)
Close on Nov 13, 2026Market cap $474.01MP/E –Yield –
DiaMedica Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
DiaMedica Therapeutics's revenue for the twelve months ending Dec 31, 2018 was $500.00K. For fiscal 2018 it was $500.00K.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $500.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $500.00K | – |
See a number that looks wrong?